West Virginia Intellectual Property Cases
Cases 51 - 60 of 283
Subaru of America, Inc. v. A & B Sales, Inc. et al
as 5:2019cv00221
Defendant:
A & B Auto Sales, Inc. and A & B Sales, Inc.
Plaintiff:
Subaru of America, Inc.
Cause Of Action: 15 U.S.C. § 1051
Novartis Pharmaceuticals Corporation v. Mylan Pharmaceuticals Inc.
as 1:2019cv00128
Defendant:
Mylan Pharmaceuticals Inc.
Plaintiff:
Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 271
Vifor (International) AG et al v. Mylan Laboratories Ltd.
as 1:2019cv00126
Plaintiff:
American Regent, Inc. and Vifor (International) AG
Defendant:
Mylan Laboratories Ltd.
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation et al v. Mylan Pharmaceuticals Inc.
as 1:2019cv00120
Defendant:
Mylan Pharmaceuticals Inc.
Plaintiff:
Novartis Pharmaceuticals Corporation and Novartis AG
Cause Of Action: 35 U.S.C. § 271
Merck Sharp & Dohme Corp. v. Mylan Pharmaceuticals Inc. et al
as 1:2019cv00101
Defendant:
Mylan Pharmaceuticals Inc. and Mylan Inc.
Plaintiff:
Merck Sharp & Dohme Corp.
Cause Of Action: 35 U.S.C. § 271
Pfizer Inc. et al v. Mylan Pharmaceuticals Inc. et al
as 1:2019cv00097
Plaintiff:
Pfizer Manufacturing Holdings LLC, Pfizer PFE Ireland Pharmaceuticals Holding 1 B.V., Pfizer Inc. and others
Defendant:
Mylan Pharmaceuticals Inc. and Mylan Inc.
Cause Of Action: 35 U.S.C. § 271
Keryx Biopharmaceuticals, Inc et al v. Mylan Pharmaceuticals Inc.
as 1:2019cv00040
Plaintiff:
Chen Hsing Hsu, Panion & BF Biotech, Inc. and Keryx Biopharmaceuticals, Inc
Defendant:
Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271
Valeant Pharmaceuticals North America LLC et al v. Mylan Pharmaceuticals Inc. et al
as 1:2019cv00037
Plaintiff:
Kaken Pharmaceutical Co., LTD., Dow Pharmaceutical Sciences, Inc., Valeant Pharmaceuticals Ireland LTD and others
Defendant:
Mylan Pharmaceuticals Inc., Mylan Inc. and Mylan Laboratories Ltd.
Cause Of Action: 35 U.S.C. § 271
Japan Tobacco Inc. v. Mylan Pharmaceuticals Inc.
as 1:2019cv00012
Plaintiff:
Japan Tobacco Inc.
Defendant:
Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271
Vient v. Ogden
as 5:2019cv00009
Defendant:
Ogden
Plaintiff:
Benjamin Vient
Cause Of Action: 17 U.S.C. § 101
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
